Case File
efta-01884939DOJ Data Set 10OtherEFTA01884939
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01884939
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey Epstein
From:
Barrett, Paul S
Sent
Thur 5/10/2012 2:39:39 PM
Subject: RE: Re:
Nope
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Thursday, May 10, 2012 10:34 AM
To: Barrett, Paul S
Subject: Re:
we didn't do csco did we??
On Thu, May 10, 2012 at 10:32 AM, Barrett, Paul S
wrote:
I know — you have to do a portfolio approach for these. On $50K premiums spent: PCLN we unwound for
a$2UK profit; CSCO lost $40K. We have done 8 so far this earnings season and 6 have been winners.
Losers have been bigger than the winners but overall positive on the strategy.
EFTA_R1_00300052
EFTA01884939
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
From: Jeffrey Epstein [mailtoueeyacation(d'ornall.com]
Sent: Thursday, May 10, 2012 10:05 AM
To: Barrett, Paul S
Subject:
looks like the cisco trade was a born loser
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
EFTA_R1_00300053
EFTA01884940
confidentiality, legal privilege, and legal entity disclaimers, available at
http://www.ipmorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00300054
EFTA01884941
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.